We are live on ! Find out more
MBII

Marrone Bio Innovations, Inc.

Delisted

MBII was delisted on the 12th of July, 2022.

49 hedge funds and large institutions have $49M invested in Marrone Bio Innovations, Inc. in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 13

6% less funds holding

Funds holding: 5249 (-3)

27% less capital invested

Capital invested by funds: $67.1M → $49M (-$18.1M)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
49
Holders Change
-3
Holders Change %
-5.77%
% of All Funds
0.97%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
3
Increased
17
Reduced
13
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
VOYA Investment Management
26
VOYA Investment Management
Georgia
$36K +$3.75K +3,095 +9%
AIG
27
American International Group
New York
$33K -$331 -273 -0.8%
State Board of Administration of Florida Retirement System
28
State Board of Administration of Florida Retirement System
Florida
$32K
Squarepoint
29
Squarepoint
New York
$23K +$27.2K +22,447 New
New York State Common Retirement Fund
30
New York State Common Retirement Fund
New York
$21K
Deutsche Bank
31
Deutsche Bank
Germany
$18K +$4.31K +3,555 +24%
Citigroup
32
Citigroup
New York
$17K +$11K +9,098 +122%
Bank of America
33
Bank of America
North Carolina
$16K -$4.79K -3,948 -20%
RJFSA
34
Raymond James Financial Services Advisors
Florida
$13K
AF
35
Allworth Financial
California
$11K
SG Americas Securities
36
SG Americas Securities
New York
$11K +$13.4K +11,056 New
Legal & General Group
37
Legal & General Group
United Kingdom
$10K +$2.32K +1,917 +24%
BNP Paribas Financial Markets
38
BNP Paribas Financial Markets
France
$7.79K -$1.44K -1,186 -13%
Bank of Montreal
39
Bank of Montreal
Ontario, Canada
$7K -$15.8K -12,992 -66%
AIP
40
Ameritas Investment Partners
Nebraska
$5K
AG
41
Advisor Group
Arizona
$4K
CFA
42
Carroll Financial Associates
North Carolina
$2K
GRP
43
Global Retirement Partners
California
$1K
GI
44
Gradient Investments
Minnesota
$1K
LTFS
45
Ladenburg Thalmann Financial Services
Florida
$1K
FDCDDQ
46
Federation des caisses Desjardins du Quebec
Quebec, Canada
$505
Jane Street
47
Jane Street
New York
-$35K -24,612 Closed
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
-$33K -23,649 Closed
CAN
49
Claraphi Advisory Network
United States
-$21K -14,863 Closed
Victory Capital Management
50
Victory Capital Management
Texas
-$21K -14,555 Closed

MBII Hedge Fund Activity: Q4 2019 in Review

49 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q4 2019, worth a combined $49M — down 27% from $67.1M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of MBII and 3 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 17 added.

The largest buyer was Ardsley Advisory Partners, adding an estimated $1.06M. The largest seller was Waddell & Reed Financial, cutting an estimated $380K.

  • 49 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q4 2019, down from 52 in Q3 2019.
  • Funds reported $49M of Marrone Bio Innovations, Inc. stock for Q4 2019, down 27% quarter-over-quarter.
  • 3 funds opened new Marrone Bio Innovations, Inc. positions in Q4 2019 and 6 closed out, a net change of -3 holders.
  • The largest Marrone Bio Innovations, Inc. buyer in Q4 2019 was Ardsley Advisory Partners, an estimated $1.06M added.
  • The largest Marrone Bio Innovations, Inc. seller in Q4 2019 was Waddell & Reed Financial, an estimated $380K sold.

Based on aggregated 13F filings for Q4 2019.